3058-0358

De Remediis

De Remediis

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Deposit reference lists for 20 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact20 DOIs
2

Attach ORCID iDs across 1 article

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact1 DOIs

DOIs for this ISSN

Showing the top 5 of 20 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Oral Testosterone Undecanoate Formulations for Testosterone… (10.71116/957htk80)
References
7.53 1
2 Medicines for influencing the posttranslational modification… (10.71116/2rks7z60)
References
0.00 0
3 Estimation of Renal Function for Antibiotic Dosing Decision (10.71116/52x6hg73)
References ORCID
0.00 0
4 Comparative study of different gel bases with herbal and syn… (10.71116/54f2ky83)
References
0.00 0
5 The Role of KRAS in Macropinocytosis and its Implications of… (10.71116/5dnpq106)
References
0.00 0
6 Hot-melt extrusion – filament manufacturing coupled with fus… (10.71116/5q06sr53)
References
0.00 0
7 From toxic materials to food-grade materials: A major challe… (10.71116/7qz2f897)
References
0.00 0
8 Avacincaptad pegol, the second approved aptamer medicine – A… (10.71116/8n3dc940)
References
0.00 0
9 Personalized 3D-Printed Gastroretentive Drug Forms with Metr… (10.71116/hths5v16)
References
0.00 0
10 Toward synthesis of thioglycosyl-phosphonate analogues of li… (10.71116/jkhmce34)
References
0.00 0
11 How can a cuttlefish avoid running out of fuel? (10.71116/k5qnn214)
References
0.00 0
12 New anticancer medicines approved by the EMA in 2024 (10.71116/ksgqxh79)
References
0.00 0
13 New anticancer medicines approved by the EMA in 2025 (10.71116/qkf6by41)
References
0.00 0
14 Comparison and evaluation of the efficacy of topical drug fo… (10.71116/rfgdv406)
References
0.00 0
15 Process optimization for in-house, lab scale pellet bead pro… (10.71116/sz7v2546)
References
0.00 0
16 Formulation and Evaluation of Topical Dosage Forms Containin… (10.71116/tef0zx77)
References
0.00 0
17 To be or not to be manipulated by our bacteria? (10.71116/vj4jx563)
References
0.00 0
18 Comparative Evaluation of Solubilization Strategies for an A… (10.71116/vmp9sc07)
References
0.00 0
19 Biotechnological techniques in the production of plant-made… (10.71116/wrst8084)
References
0.00 0
20 Formulation and investigation of Lactobacillus rhamnosus cek… (10.71116/ws5t3n82)
References
0.00 0